AIFD
TR EN    
Home Page » ABOUT US » Charter » Membership
Charter

4. PREREQUISITIES FOR MEMBERSHIP

Natural or juristic persons represented or incorporated in Turkey, with or without foreign affiliation and capable of transacting legally , who operate in the pharmaceutical sector are eligible to become a member. All companies and their representatives who become members of the Association shall be
considered to have acceded to the Charter and to the Code of Promotional Practice of the Association.


According to the ranked cumulative IMS MAT market shares the board shall propose the minimum allocation of memberships per company, subject to approval by the members each year at the General Assembly.


For the period of May 2007-April 2008; according to the turnover share of the member companies based on the latest available IMS MAT sales data in USD, member companies may be represented in the Association by 8 members for those holding the top 2 ranks (cumulative market share of 0 to 25 %), by 6 members for the consequent 3 companies  (cumulative market share of 25 to 50 %) , by 4 members for the consequent 8 companies(cumulative market share of 50 to 80 %) , by 2 members for the consequent 7 companies (cumulative market share of 80 to 95 %) , and by 1 member for the remaining companies (cumulative market share of 95-100 %) .


Member companies might be represented by more members than the number of membership allocated to that specific category if they so wish and pay accordingly. In accordance with article 13.2 of the charter, member companies shall pay per representative the annual dues designated in the general assembly. The annual dues might be paid as a whole following the general assembly or in two installments; two thirds of the total amount after the general assembly and one third in following January.

Any companies or company representatives becoming a member after January shall prepay the membership due for 6 (six) months only, i.e. one half (50%) of the annual membership due.

MEMBER LOGIN
İşletim sisteminiz Flash Ögeleri Desteklemiyor. Yüklemek için tıklayınız.
INSIDER AIFD
Right strategies will lead Turkey to a bright future
SEARCH IN SITE
DID YOU KNOW THAT…? IMPORTANT TERMS SITE MAP USEFUL LINKS CONFIDENTIALITY-TERMS OF USE CONTACT
AbbottActelion AIFDAlcon Alexion İlaç Ticaret Ltd. Şti.Allergan İlaçları Ticaret A.Ş. AmgenAstellasAstraZeneca Bausch+Lomb Sağlık Optik Ürünleri Tic. A.Ş.Bayer Türk Kimya San. Ltd. Şti. Boehringer IngelheimBristol-Myers SquibbCelgeneChiesiDaiichi-SankyoEczacıbaşı-BaxterFerring Fresenius KabiGilead Sciences İlaç.Tic. Ltd. Şti.GlaxoSmithKlineIBSA İlaç San. ve Tic. Ltd. Şti.Intendis ISectionİ.E.UlagayJohnson&JohnsonLillyLundbeck İlaç Tic.Ltd. Şti. Merck SeronoMSD TürkiyeNestle Novartis Sağlık Ürünleri Novo NordiskNutricia Klinik BeslenmeOTHERSPfizer İlaçları Ltd. ŞtiRoche Müstahzarları San. A.Ş.Sanofi-aventisServier Takeda İlaçları Tic Ltd Şti U.C.B. Pharma
AİFD is a member of IFPMA – International Federation of Pharmaceutical Manufacturers and Associations and EFPIA (European Federation of Pharmaceutical Industries and Associations).    
© Association of Research-Based Pharmaceutical Companies Last Update : 02.02.2012
XHTML 1.1 CSS